USPTO serial 85175434
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
PHILADELPHIA, PA
University of the Sciences in Philadelphia
Philadelphia, PA
Other trademarks owned by University of the Sciences in Philadelphia
University of the Sciences in Philadelphia
Philadelphia, PA
Other trademarks owned by University of the Sciences in Philadelphia
University of the Sciences in Philadelphia
Philadelphia, PA
Other trademarks owned by University of the Sciences in Philadelphia
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D. Olszyk, Jr.
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 035 | [ Business consulting services for the pharmaceutical and health care industries, namely, pharmaceutical care management programs in the nature of cost management and drug utilization review for pharmaceutical benefit plans for private and public agencies, organizations, institutions, and individuals; Business research services, namely, providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy utilization and costs reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly, namely, drug utilization review research for the pharmaceutical and health care industries ] | SECTION 8 - CANCELLED | Sep 1, 2010 |
| 036 | [ Providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, research about patient reimbursement for pharmaceuticals and financing the research of others in the field of pharmacoeconomics; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, financing the research of others ] | SECTION 8 - CANCELLED | Sep 1, 2010 |
| 041 | Educational services, namely, providing courses of instruction at the undergraduate, graduate, and post-graduate levels; educational services, namely, providing educational undergraduate, graduate, and post-graduate level research programs for all aspects of pharmaceutical study; providing continuing education conferences, seminars and workshops in the fields of pharmaceutical study, health care, and health sciences; conducting educational conferences and seminars in the fields of the study of pharmacy and the pharmaceutical and health care industries; publication of newsletters, news briefs, and monographs for pharmacists and health care professionals; entertainment services in the nature of presentation of a variety of intercollegiate sporting events, namely, cross-country running, [ cheerleading, rifle, ] basketball, baseball, golf, tennis, softball, and volleyball | SECTION 8 - CANCELLED | Sep 1, 2010 |
| 042 | [ Technical consulting services in the nature of pharmaceutical technology consulting for pharmaceutical care management programs provided to private and public agencies, organizations, institutions, and individuals for the pharmaceutical and health care industries; Research consulting services in the nature of pharmaceutical research services for pharmaceutical care management programs for private and public agencies, organizations, institutions, and individuals in the pharmaceutical and health care industries; providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy selection, utilization, costs, and reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, pharmaceutical research services; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, research in the field of pharmaceuticals ] | SECTION 8 - CANCELLED | Sep 1, 2010 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 10, 2023 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 27, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 28, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 14, 2018 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 14, 2018 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 24, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 16, 2018 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 28, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 28, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 20, 2012 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jul 16, 2012 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 25, 2012 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 25, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 29, 2012 | IUAF | USE AMENDMENT FILED | — |
| May 29, 2012 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 29, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 4, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 1, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 31, 2011 | ALIE | ASSIGNED TO LIE | — |
| Aug 18, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2011 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 26, 2011 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 26, 2011 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 23, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Nov 17, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2010 | NWAP | NEW APPLICATION ENTERED | — |